ARGX logo

ARGXArgenx

$832.01
$4.08
(0.49%)
Pre-Market
Updated: 04:39 AM EDT·Prev Close $836.09
Reported EarningsMay 7
Mkt Cap$51.74B
Vol2.00

About

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
1,863

Frequently Asked Questions

What is Market Cap of Argen X SE - ADR?
What is the 52-week high for Argen X SE - ADR?
What is the 52-week low for Argen X SE - ADR?
What is Argen X SE - ADR stock price today?
What was Argen X SE - ADR stock price yesterday?
What is the PE ratio of Argen X SE - ADR?
What is the Price-to-Book ratio of Argen X SE - ADR?
What is the 50-day moving average of Argen X SE - ADR?
How many employees does Argen X SE - ADR have?